4//SEC Filing
DIVIS GREG J 4
Accession 0001567619-19-012607
CIK 0001012477other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 5:39 PM ET
Size
12.9 KB
Accession
0001567619-19-012607
Insider Transaction Report
Form 4
DIVIS GREG J
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2019-05-30+400,000→ 400,000 totalExercise: $1.71Exp: 2029-05-30→ ADSs (400,000 underlying)
Holdings
- 100,000
Stock Option (right to buy)
Exercise: $8.95Exp: 2027-12-12→ ADSs (100,000 underlying) - 100,000
Stock Option (right to buy)
Exercise: $1.85Exp: 2029-03-07→ ADSs (100,000 underlying) - 67,100
ADSs
- 150,000
Stock Option (right to buy)
Exercise: $10.40Exp: 2026-12-14→ ADSs (150,000 underlying) - 50,000
Stock Option (right to buy)
Exercise: $7.06Exp: 2028-03-22→ ADSs (50,000 underlying)
Footnotes (7)
- [F1]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
- [F2]Includes (a) 22,500 restricted shares granted under the issuer's Omnibus Incentive Compensation Plan on 12/12/2017, under which 15,000 ADSs will vest and be issued on the second anniversary of the grant date and the remaining 7,500 ADSs will vest and be issued on the third anniversary of the grant date (with vesting of these restricted shares subject to the reporting person remaining in continuous service until the applicable anniversary of the date of grant); and (b) 18,000 restricted ADSs granted under the issuer's Omnibus Incentive Compensation Plan on 3/7/2019, of which 12,000 and 6,000 ADSs will vest and be issued to the reporting person on the 2nd anniversary and 3rd anniversary, respectively, of the grant date (with such vesting subject to the reporting person remaining in continuous service until the applicable anniversary).
- [F3]Options become exercisable as to 37,500 ADSs on each of the first four anniversaries after the 12/14/2016 grant date.
- [F4]Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 12/12/2017 grant date.
- [F5]Options become exercisable as to 12,500 ADSs on each of the first four anniversaries after the 3/22/2018 grant date.
- [F6]Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 3/7/2019 grant date.
- [F7]Options become exercisable as to 100,000 ADSs on each of the first four anniversaries after the 5/30/2019 grant date.
Documents
Issuer
AVADEL PHARMACEUTICALS PLC
CIK 0001012477
Entity typeother
Related Parties
1- filerCIK 0001410677
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 5:39 PM ET
- Size
- 12.9 KB